| Date Filed | Type | Description |
| 06/16/2023 |
4
| Schenkein David P (Director) has filed a Form 4 on Prime Medicine, Inc.|
Txns:
| Granted 39,062 options to buy
@ $14.83, valued at
$579.3k
|
|
| 06/05/2023 |
4
| Schenkein David P (Director) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Granted 4,216 shares
@ $0
Granted 12,649 options to buy
@ $30.92, valued at
$391.1k
|
|
| 04/05/2023 |
4
| Schenkein David P (Director) has filed a Form 4 on AGIOS PHARMACEUTICALS, INC.|
Txns:
| Sold 16,363 shares
@ $22.85, valued at
$373.9k
Exercised 16,363 options to buy
@ $9.05, valued at
$148.1k
|
|
| 03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/15/2023 |
4
| Schenkein David P (Director) has filed a Form 4 on AGIOS PHARMACEUTICALS, INC.|
Txns:
| Sold 18,333 shares
@ $22.47, valued at
$411.9k
Sold 1,667 shares
@ $22.72, valued at
$37.9k
Exercised 20,000 options to buy
@ $9.05, valued at
$181k
|
|
| 03/01/2023 |
4
| Schenkein David P (Director) has filed a Form 4 on AGIOS PHARMACEUTICALS, INC.|
Txns:
| Sold 20,000 shares
@ $25.37, valued at
$507.4k
Exercised 20,000 options to buy
@ $9.05, valued at
$181k
|
|
| 02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/19/2023 |
4
| Schenkein David P (Director) has filed a Form 4 on AGIOS PHARMACEUTICALS, INC.|
Txns:
| Sold 18,966 shares
@ $28.82, valued at
$546.6k
Sold 1,034 shares
@ $29.49, valued at
$30.5k
Exercised 20,000 options to buy
@ $9.05, valued at
$181k
|
|
| 10/19/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2022 |
4
| Schenkein David P (Director) has filed a Form 4 on AGIOS PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 758 shares
@ $29.08, valued at
$22k
Exercised 2,775 restricted stock units
@ $0 |
|
| 06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2021 |
4
| Schenkein David P (Director) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Exercised 3,253 restricted stock units
@ $0 |
|
| 06/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/23/2020 |
4
| Schenkein David P (Director) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Sold 25,000 shares
@ $90.0622, valued at
$2.3M
Sold 5,000 shares
@ $90.0054, valued at
$450k
|
|
| 11/13/2020 |
4
| Schenkein David P (Director) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Sold 30,000 shares
@ $70.053, valued at
$2.1M
|
|
| 11/12/2020 |
4
| Schenkein David P (Director) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Sold 10,000 shares
@ $60.031, valued at
$600.3k
|
|
| 11/06/2020 |
4
| Schenkein David P (Director) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Sold 10,000 shares
@ $50.183, valued at
$501.8k
|
|
| 06/22/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/05/2020 |
4
| Schenkein David P (Director) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Granted 15,183 options to buy
@ $28.82, valued at
$437.6k
Granted 3,253 restricted stock units
@ $0 |
|
| 06/01/2020 |
4
| Schenkein David P (Director) has filed a Form 4 on AGIOS PHARMACEUTICALS, INC.|
Txns:
| Granted 8,096 options to buy
@ $53.35, valued at
$431.9k
Granted 1,686 restricted stock units
@ $0 |
|
| 02/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/15/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2019 |
4
| Schenkein David P (Director) has filed a Form 4 on bluebird bio, Inc.|
Txns:
| Granted 1,000 shares
@ $0
Granted 4,000 options to buy
@ $122.01, valued at
$488k
|
|
| 06/03/2019 |
4
| Schenkein David P (Director) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Granted 27,245 options to buy
@ $19.5, valued at
$531.3k
|
|
| 02/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/19/2018 |
4
| Schenkein David P (CEO) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Gifted 1,000 shares
@ $0 |
|
|